The immune infiltrate in prostate, bladder and testicular tumors: An old friend for new challenges

详细信息    查看全文

• 作者：Cinzia Solinas^a ; ^{czsolinas@gmail.com} ; Nieves Martinez Chanzá ; ^b ; ^c ; ^{nieves.martinez-chanza@bordet.be} ; Ahmad Awada^b ; ^{ahmad.awada@bordet.be} ; Mario Scartozzi^d ; ^{marioscartozzi@gmail.com}
• 关键词：TIL ; Immune checkpoint molecules ; Immunotherapy ; Prostate cancer ; Bladder cancer ; Testicular tumors
• 刊名：Cancer Treatment Reviews
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：53
• 期：Complete
• 页码：138-145
• 全文大小：929 K
• 卷排序：53

文摘

In urogenital tumors immunotherapeutic drugs have shown activity and lasting responses. Identification of ideal candidates for therapy with immune checkpoint blockade represents a challenge. The presence of tumor-infiltrating lymphocytes (TIL) might guide the selection of patients for immunotherapy.